Eisele Jeffrey

CIK 00018273261 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001827326

Recent Transactions

35 trades

Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-29$29.52/sh−278→ 55,312 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-22$30.43/sh−1,291→ 55,590 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-13$28.70/sh−264→ 56,881 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-12-23$33.09/sh−63→ 57,145 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-30$65.53/sh−971→ 57,208 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-29$64.14/sh−279→ 58,179 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-23$63.69/sh−7,378→ 58,458 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-22$65.00/sh−1,607→ 65,836 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-17$65.58/sh−5,207→ 67,443 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-16+19,508→ 73,088 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2024-01-16$66.30/sh+28,367→ 28,367 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-16$66.81/sh−438→ 72,650 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-12-27$60.23/sh−235→ 53,580 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-12-26$57.86/sh−68→ 53,815 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-02-23$68.76/sh−1,646→ 53,883 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-02-21+14,023→ 14,023 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-02-21+9,886→ 56,354 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-02-21$58.50/sh−825→ 55,529 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-30$52.76/sh−883→ 46,468 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-27$52.77/sh−367→ 47,351 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-23$51.58/sh−4,479→ 47,718 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-20$52.05/sh−2,033→ 52,197 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-12+22,580→ 54,230 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-01-12$52.66/sh+35,472→ 35,472 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-12-22$51.68/sh−89→ 31,650 total
Other
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-04-25−1,250→ 31,739 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-28$38.59/sh−434→ 32,989 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-21+26,051→ 33,423 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-01-21+36,951→ 36,951 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-12-22$47.82/sh−89→ 7,372 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-03-01+7,500→ 7,500 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-03-01+1,250→ 7,461 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-01-28+5,000→ 6,211 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-01-28+30,000→ 30,000 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2020-12-23+1,211→ 1,211 total

Companies

Apellis Pharmaceuticals, Inc.
Chief Development Officer
$APLS

Recent Filings

Address

C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR

WALTHAM, MA, 02451

View on SEC.gov